Last reviewed · How we verify

NCT03054961

Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study

Completed Last updated 5 July 2024
What this trial tests

trial testing Near-infrared spectroscopy in Epilepsies, Partial in 34 participants. Completed in 7 June 2023.

Timeline
10 February 2017
Primary endpoint
7 June 2023
7 June 2023

Quick facts

Lead sponsorMedical College of Wisconsin
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date10 February 2017
Primary completion7 June 2023
Estimated completion7 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

7 and older, any sex, with Epilepsies, Partial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to describe the relationship of regional cerebral oximetry and cytoximetry, measured using near-infrared spectroscopy, with seizure activity in the periictal period in children with epilepsy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Near-infrared spectroscopy

Trials testing the same drug.

Other recruiting trials for Epilepsies, Partial

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03054961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing